BioWorld MedTech

Nov. 17, 2011

AHA notebook: Berlin Heart unveils favorable data from Excor clinical trial

The Berlin Heart Group (Woodlands, Texas/Berlin) unveiled clinical trial data presented yesterday at the "Scientific Sessions 2011" annual meeting of the American Heart Association (AHA; Washington). Read More

CooperVision recall expanded, management credibility hit

International report: Boston Sci's Watchman implanted in first Latin American patients

Washington roundup: FDA spells out new staged IDE approval in new draft guidance

Financings roundup: Unilife prices offering, expects to raise $34M

Deals roundup: AptarGroup acquires minority interest in OVal for $3.2M

Agreements/contracts: Genisphere to supply RNA technology to Affymetrix

New ventures: Optum launches institute for sustainable health

Med-Tech Notes: Digital Assent opens more offices

HIT roundup: Methodist Hospital to deploy SciQuest's eMarketplace

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 14, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...